Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Saturday, 30 March 2024
ARADIGM CORP
NASDAQ
ARDM
Summary
|
Chart
|
News
|
History
|
More info..
NASDAQ : ARDM
0.3800
14 Jan 19 00:00
Change:
0.08
Open:
0.4500
High:
0.5000
Ask:
0.0000
Volume:
412,300
Change(%):
17.39
Prev:
0.4600
Low:
0.3800
Bid:
0.0000
Avg vol:
0
Latest News
More news...
Glancy Prongay & Murray LLP Reminds Investors of the March 12, 2018 Deadline ...
03:26 | 13/3/18
Business Wire
To obtain information or actively participate in the class action, please visit the Aradigm page on our website at www.glancylaw.com/case/aradigm-corporation. Investors that suffered losses on their Aradigm investments are encouraged to contact Lesley ...
more»
Aradigm Files MAA for Bronchiectasis Candidate in the EU
03:26 | 13/3/18
Zacks.com
Aradigm Corporation's (ARDM - Free Report) shares increased almost 3% on Mar 9 after the company announced submission of marketing authorization application (MAA) to European Medicines Agency (EMA) for its lead candidate, Linhaliq.
more»
Aradigm Corp. (ARDM) Submits MAA to EMA for EU Marketing Approval of Linhaliq ...
01:56 | 10/3/18
StreetInsider.com
Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced it has submitted its Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients ...
more»
ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered ...
12:03 | 9/3/18
Business Wire
The lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all those who purchased Aradigm common stock between July 27, 2017 and January 8, 2018 (the “Class Period”).
more»
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action ...
11:07 | 9/3/18
Business Wire
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors that purchased Aradigm Corporation (“Aradigm” or the “Company”) (NASDAQ: ARDM) securities between July 27 ...
more»
Comments
There are currently no comments on this topic.
Be the first person to Add a Comment...
ADD USER TO MY FAVOURITE
Customize your favourite:
Send me an alert when this user publishes new articles.
Add a Comment
You must be a registered user to post a comment:
REGISTER NOW
If you are already registered, please
LOGIN NOW
Add to Watchlist
Add to Portfolio
Add Email Alert
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
Most Viewed Stories
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%
Newsletters
Email Address:
Weekly Newsletter
Daily Market Report
Daily Forex Report
Daily Global Report